Adaptive Biotechnologies (ADPT) Stock Price, Quote, News & History | Benzinga

Adaptive Biotechnologies Corp (ADPT) Stock Price, Quote, News & History

ADPTNASDAQ

Trade with Public

Trade with Public

$25.99

0.552.16%

At close: Aug 21, 5:00 PM EST

$25.99

N/A

After Hours: 4:37 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$25.37

Close

$25.99

Volume / Avg.

1.82M / 2.93M

Day Range

$24.93 - $26.03

52 Wk Range

12.00 - 26.16

Market Cap

$4.15B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

65

Short Interest

9.89%

Days to Cover

4.39

Recent Adaptive Biotechnologies Corporation News

KB Home Posts Upbeat Q2 Sales, Joins Inmode, Icon And Other Big Stocks Moving Higher On Wednesday

U.S. stocks rose, with Nasdaq up 50 points. KB Home (NYSE: KBH) reported strong Q2 results, shares jumped 16.2%. Other big gainers: WEN, ABSI, RUN, CCXI, ENRD, SFTX, ICCM, INMD, DFH.

Avi Kapoor

Adaptive Biotechnologies Business Separation May Unlock Greater Value

William Blair says Adaptive's Immune Medicine separation could sharpen the MRD story, improve flexibility and support valuation.

Vandana Singh

Adaptive Biotechnologies Stock Rises On Plan To Split MRD, Immune Medicine Businesses

Adaptive Biotechnologies plans to separate its businesses as clonoSEQ profitability and revenue growth accelerate.

Vandana Singh

Stock Market Today: S&P 500, Nasdaq Futures Fall, Dow Gains Amid US-Iran Deal— SpaceX, Dave And Buster's, Western Digital In Focus (UPDATED)

(Editor’s note: The lede, headline, futures and economic data were updated.) U.S. stock futures were mixed on Tuesday, as the Dow Jones rose, while the Nasdaq 100 and S&P 500 declined, following Monday’s rally. The Labor Department reported that U.S. import prices advanced 1.9% in May, driven by surging fuel costs.

Rishabh Mishra

Dave and Buster's Reports Downbeat Q1 Earnings, Joins Alvotech And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

US stock futures up 0.1%, Dave and Buster's (PLAY) down 13.4% pre-market due to lower earnings; other stocks declining in pre-market trading

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-21.01M

Investing Cash Flow (TTM)

-25.30M

Financing Cash Flow (TTM)

173.03M

Free Cash Flow (TTM)

-24.03M

Capital Expenditure (TTM)

-3.03M

Net Change in Cash (TTM)

126.72M

Analyst Trends and Forecast

4

1

May

2

Jun

3

2

Jul

1

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.4

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$4.13B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

12.82

PB Ratio (TTM)

28.41

Earnings Yield % (TTM)

-1.57%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.90

Company Debt

Total Debt

$334.88M

LT Debt

$334.88M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$169.87M

Debt to Equity

2.87

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$25.37

Close

$25.99

Volume / Avg.

1.82M / 2.93M

Day Range

$24.93 - $26.03

52 Wk Range

12.00 - 26.16

Market Cap

$4.15B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

65

Short Interest

9.89%

Days to Cover

4.39

About

Sector

Health Care

Industry

Life Sciences Tools & Services

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, ...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Adaptive Biotechnologies (ADPT) stock?

A

You can purchase shares of Adaptive Biotechnologies (NASDAQ:ADPT) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Adaptive Biotechnologies (ADPT) competitors?

A

Other companies in Adaptive Biotechnologies’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corp (NYSE:DHR), Agilent Technologies Inc (NYSE:A), IQVIA Holdings Inc (NYSE:IQV) and Waters Corp (NYSE:WAT).

Q

What is the forecast, or price target, for Adaptive Biotechnologies (ADPT) stock?

A

Adaptive Biotechnologies has a consensus price target of $20.35.

Q

What is the current price for Adaptive Biotechnologies (ADPT)?

A

The stock price for Adaptive Biotechnologies (NASDAQ: ADPT) is $25.99 last updated August 21, 2026 at 4:37 PM EDT.

Q

Does Adaptive Biotechnologies (ADPT) pay a dividend?

A

There are no upcoming dividends for Adaptive Biotechnologies.

Q

When is Adaptive Biotechnologies (NASDAQ:ADPT) reporting earnings?

A

Adaptive Biotechnologies does not have any upcoming earnings scheduled.

Q

Is Adaptive Biotechnologies (ADPT) going to split?

A

There is no upcoming split for Adaptive Biotechnologies.

Q

What sector and industry does Adaptive Biotechnologies (ADPT) operate in?

A

Adaptive Biotechnologies is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.